Skip to content

Exploratory study on somatic mutation detection using plasma DNA from patients with lung cancer

Exploratory study on somatic mutation detection using plasma DNA from patients with lung cancer - Mutation detection using plasma DNA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021711
Enrollment
80
Registered
2016-03-31
Start date
2014-12-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

One blood draw (15 mL)

Sponsors

Third Department of Internal Medicine, Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Lung cancer patients who are pathologically or cytologically confirmed

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Feasibility

Countries

Japan

Contacts

Public ContactYasuhiro Koh

Wakayama Medical University Third Department of Internal Medicine

ykoh@wakayama-med.ac.jp073-441-0619

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026